Pipeline

ProgramDiseasesDiscoveryPreclinicalPhase 1Phase 2Phase 3
ATYR1923 Pulmonary Sarcoidosis
Other ILDs (CTD-ILD; CHP)(1)
COVID-19 related severe respiratory complications
NRP2 Antibodies Cancer; Inflammation
tRNA Synthetase Candidates Immunology
Program Target Phase
ATYR1923 Pulmonary Sarcoidosis Phase 2
Other ILDs (CTD-ILD; CHP)(1) Phase 1
COVID-19 related severe respiratory complications Phase 2
NRP2 Antibodies Cancer; Inflammation Discovery
tRNA Synthetase Candidates Immunology Discovery


(1)
CTD-ILD = connective tissue disease-related ILD; CHP = chronic hypersensitivity pneumonitis